P2.04-92 Neoadjuvant Durvalumab With or Without Sub-Ablative Stereotactic Radiotherapy (SBRT) in Patients with Resectable NSCLC (NCT02904954).
| Autor: | Altorki, N., Borczuk, A., Saxena, A., Port, J., Stiles, B., Lee, B., Sanfilippo, N., Ko, E., Scheff, R., Pua, B., Gruden, J., Christos, P., Spinelli, C., Gakuria, J., Mittal, V., Mcgraw, T., Formenti, S. |
|---|---|
| Zdroj: | Journal of Thoracic Oncology; 2019 Supplement, Vol. 14, pS746-S746, 1p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|